HHealth Read More The share of Americans medically obese is projected to rise to almost 50% by 2035January 30, 2026 On Wednesday, a new study published in JAMA by researchers at the University of Washington in Seattle projected…
HHealth Read More Expert guide to all the types of GLP-1 drugs available in 2026January 30, 2026 Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word…
MMedication Read More US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable TherapyJanuary 29, 2026 The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
FFitness Read More Alison Hammond’s 11 stone weight loss secret revealed after one ‘drastic’ changeJanuary 27, 2026 Alison Hammond looks incredible after undergoing a serious fitness journey in recent yearsNicola Croal Trends, Showbiz and Lifestyle…
HHealth care Read More Roche moves obesity drug to pivotal trials after mid-stage successJanuary 27, 2026 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?January 26, 2026 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
NNutrition Read More Which breads are best — and the ‘healthy’ kind you should avoidJanuary 23, 2026 Bread is, well, on a roll. Though the average price of bread rose about 2.2% in the last…
MMedication Read More 6 New Weight Loss Drugs That Could Dethrone OzempicJanuary 22, 2026 The arrival of semaglutide and similar GLP-1 drugs in recent years has ushered in a new era of…
HHealth Read More Bariatric surgery beats GLP-1s for type 2 diabetes, study findsJanuary 20, 2026 When endocrinologist Mary Elizabeth Patti looks at a patient with type 2 diabetes who could benefit from weight…
MMedication Read More Weight loss drug Wegovy to be subsidised for Australians with severe obesityJanuary 16, 2026 An Ozempic-like medication is set to be listed on the Pharmaceutical Benefits Scheme shortly, saving patients with “severe”…
MMedication Read More How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?January 16, 2026 Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
MMedication Read More The Truth About Weight-Loss Drugs Like Ozempic: You Probably Need Them ForeverJanuary 15, 2026 Weight-loss drugs like Wegovy require a lifetime commitment. Stop taking them, and you’ll almost always gain back the…